Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
2.
BMC Infect Dis ; 15: 475, 2015 Oct 28.
Article in English | MEDLINE | ID: mdl-26511929

ABSTRACT

BACKGROUND: Multidrug-resistant Escherichia coli and other enteric bacteria producing extended-spectrum ß-lactamases (ESBL) have emerged as an important cause of invasive infection. Targeting the primary (intestinal) niche by decolonization may be a valuable approach to decrease the risk of relapsing infections and to reduce transmission of ESBL-producing enteric pathogens. METHODS: In a retrospective observational study we evaluated the efficacy of intestinal decolonization treatment using orally administered colistin or other non-absorbable agents given for 2 to 4 weeks in adult patients with previous relapsing infection and persistent intestinal colonization with ESBL-positive Enterobacteriaceae (ESBL-E). Eradication success was defined as negative rectal swab or stool culture at the end of treatment and at follow up-2 weeks after treatment discontinuation. RESULTS: First-line decolonization treatment led to eradication of ESBL-E in 19/45 patients (42%, 7/18 low-dose [4 × 1 million units] colistin, 3/12 high-dose [4 × 2 million units] colistin, 9/15 rifaximin [2 × 400 mg]), and secondary/salvage treatment was successful in 8/13 patients (62 %, 20 treatment episodes). Late follow-up showed that 7/13 patients (54%) with successful initial or salvage decolonization became recolonized within 3 months after post-treatment assessment while all eight of the patients failing initial or salvage decolonization treatment with late follow-up remained colonized. A narrative review of the literature confirms the limited efficacy of non-absorbable antibiotics including conventional selective digestive tract decolonization (SDD)-like combination regimens for eradicating multidrug-resistant enteric bacteria from the intestinal tract. CONCLUSIONS: At present, there is no clear evidence of a significant decolonization efficacy using single-drug treatment with oral non-absorbable antibiotics. More effective regimens are needed and a better definition of at risk patients is required for planning meaningful randomized controlled studies in this field.


Subject(s)
Colistin/therapeutic use , Enterobacteriaceae Infections/prevention & control , Enterobacteriaceae/drug effects , beta-Lactamases/metabolism , Administration, Oral , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Colistin/administration & dosage , Drug Resistance, Multiple, Bacterial/drug effects , Enterobacteriaceae/metabolism , Enterobacteriaceae/pathogenicity , Enterobacteriaceae Infections/microbiology , Escherichia coli/drug effects , Escherichia coli/metabolism , Escherichia coli/pathogenicity , Female , Gastrointestinal Microbiome/drug effects , Humans , Intestines/drug effects , Intestines/microbiology , Male , Middle Aged , Retrospective Studies , Rifamycins/therapeutic use , Rifaximin , Treatment Outcome , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...